Law Suit by Invitae against Myriad regarding BRCA1/2 & MUTYH gene patent infringement

A case had been filed on Myriad Genetics by the Invitae Corporation in U.S. district court. The case demands a formal announcement from Myriad Genetics and withdrawal of all the charges on Invitae, as in an earlier case filed by the Myriad Genetics marked Invitae as defendant in an infringement case. In the reply, Invitae Co. said that Myriad certain …

Playing with Patent Law: Profit Making Scheme

On June 13, 2013 Supreme Court of US ordered that naturally occurring genes and the information encoded by them will not be patented, though artificially synthesized ones can be. The issue came to picture when patent was filed by Myriad for BRCA 1 and BRCA2, which are human genes related to breast and ovarian cancer respectively. Myriad genetics is …